Tosca, E.M.; Rocchetti, M.; Pérez, E.; Nieto, C.; Bettica, P.; Moscoso del Prado, J.; Magni, P.; De Nicolao, G.
In Vitro–In Vivo Correlation (IVIVC) Population Modeling for the In Silico Bioequivalence of a Long-Acting Release Formulation of Progesterone. Pharmaceutics 2021, 13, 255.
https://doi.org/10.3390/pharmaceutics13020255
AMA Style
Tosca EM, Rocchetti M, Pérez E, Nieto C, Bettica P, Moscoso del Prado J, Magni P, De Nicolao G.
In Vitro–In Vivo Correlation (IVIVC) Population Modeling for the In Silico Bioequivalence of a Long-Acting Release Formulation of Progesterone. Pharmaceutics. 2021; 13(2):255.
https://doi.org/10.3390/pharmaceutics13020255
Chicago/Turabian Style
Tosca, Elena M., Maurizio Rocchetti, Elena Pérez, Conchi Nieto, Paolo Bettica, Jaime Moscoso del Prado, Paolo Magni, and Giuseppe De Nicolao.
2021. "In Vitro–In Vivo Correlation (IVIVC) Population Modeling for the In Silico Bioequivalence of a Long-Acting Release Formulation of Progesterone" Pharmaceutics 13, no. 2: 255.
https://doi.org/10.3390/pharmaceutics13020255
APA Style
Tosca, E. M., Rocchetti, M., Pérez, E., Nieto, C., Bettica, P., Moscoso del Prado, J., Magni, P., & De Nicolao, G.
(2021). In Vitro–In Vivo Correlation (IVIVC) Population Modeling for the In Silico Bioequivalence of a Long-Acting Release Formulation of Progesterone. Pharmaceutics, 13(2), 255.
https://doi.org/10.3390/pharmaceutics13020255